CN101195587B - 一种碘克沙醇水解物的制备方法 - Google Patents
一种碘克沙醇水解物的制备方法 Download PDFInfo
- Publication number
- CN101195587B CN101195587B CN2006101553229A CN200610155322A CN101195587B CN 101195587 B CN101195587 B CN 101195587B CN 2006101553229 A CN2006101553229 A CN 2006101553229A CN 200610155322 A CN200610155322 A CN 200610155322A CN 101195587 B CN101195587 B CN 101195587B
- Authority
- CN
- China
- Prior art keywords
- visipaque
- hydrolyzate
- preparation
- benzenedicarboxamide
- iodo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 239000000413 hydrolysate Substances 0.000 title abstract 3
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 claims abstract description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 150000002500 ions Chemical class 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 30
- CRZIAMCADJKTOG-UHFFFAOYSA-N C(C)(=O)NC=1C=CC(=C(C1)[As](O)(O)=O)O Chemical compound C(C)(=O)NC=1C=CC(=C(C1)[As](O)(O)=O)O CRZIAMCADJKTOG-UHFFFAOYSA-N 0.000 claims description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- UFNGEZFIBCOLBF-UHFFFAOYSA-N NC(=O)C1=CC=CC(C(N)=O)=C1I Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1I UFNGEZFIBCOLBF-UHFFFAOYSA-N 0.000 claims description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 230000003197 catalytic effect Effects 0.000 claims description 14
- -1 amine compound Chemical class 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002608 ionic liquid Substances 0.000 claims description 8
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 150000002460 imidazoles Chemical class 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 3
- 150000004996 alkyl benzenes Chemical class 0.000 abstract description 2
- 150000001412 amines Chemical class 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 229960004359 iodixanol Drugs 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 abstract 1
- 238000010923 batch production Methods 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 238000005265 energy consumption Methods 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 description 23
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 7
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 5
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical group OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000002697 interventional radiology Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 1
- NBDAHKQJXVLAID-UHFFFAOYSA-N 5-nitroisophthalic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 NBDAHKQJXVLAID-UHFFFAOYSA-N 0.000 description 1
- XUHXFSYUBXNTHU-UHFFFAOYSA-N Iotrolan Chemical compound IC=1C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C=1N(C)C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I XUHXFSYUBXNTHU-UHFFFAOYSA-N 0.000 description 1
- 239000002616 MRI contrast agent Substances 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- YLPBXIKWXNRACS-UHFFFAOYSA-N iobitridol Chemical compound OCC(O)CN(C)C(=O)C1=C(I)C(NC(=O)C(CO)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I YLPBXIKWXNRACS-UHFFFAOYSA-N 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 239000000193 iodinated contrast media Substances 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 229960003182 iotrolan Drugs 0.000 description 1
- 229960000554 metrizamide Drugs 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101553229A CN101195587B (zh) | 2006-12-19 | 2006-12-19 | 一种碘克沙醇水解物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101553229A CN101195587B (zh) | 2006-12-19 | 2006-12-19 | 一种碘克沙醇水解物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101195587A CN101195587A (zh) | 2008-06-11 |
CN101195587B true CN101195587B (zh) | 2010-07-21 |
Family
ID=39546235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101553229A Active CN101195587B (zh) | 2006-12-19 | 2006-12-19 | 一种碘克沙醇水解物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101195587B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111606819A (zh) * | 2020-05-25 | 2020-09-01 | 浙江海洲制药有限公司 | 一种碘克沙醇水解物的制备方法 |
CN111574384B (zh) * | 2020-06-12 | 2021-03-16 | 上海馨远医药科技有限公司 | 一种手性1-氨基-2-丙醇的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1132743A (zh) * | 1995-11-20 | 1996-10-09 | 江苏省原子医学研究所 | 一种碘海醇的制备方法 |
CN1340042A (zh) * | 1999-02-11 | 2002-03-13 | 尼科梅德成像有限公司 | 碘克沙醇的制备 |
WO2005003080A1 (en) * | 2003-07-03 | 2005-01-13 | Amersham Health As | Process for iohexol manufacture |
-
2006
- 2006-12-19 CN CN2006101553229A patent/CN101195587B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1132743A (zh) * | 1995-11-20 | 1996-10-09 | 江苏省原子医学研究所 | 一种碘海醇的制备方法 |
CN1340042A (zh) * | 1999-02-11 | 2002-03-13 | 尼科梅德成像有限公司 | 碘克沙醇的制备 |
WO2005003080A1 (en) * | 2003-07-03 | 2005-01-13 | Amersham Health As | Process for iohexol manufacture |
Also Published As
Publication number | Publication date |
---|---|
CN101195587A (zh) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103601613B (zh) | 一种3,4,5-三氟溴苯的制备方法 | |
CN102675167A (zh) | 一种对甲砜基苯甲醛的制备方法 | |
CN103274959B (zh) | 一种凉味剂n,2,3-三甲基-2-异丙基丁酰胺的合成方法 | |
CN101195587B (zh) | 一种碘克沙醇水解物的制备方法 | |
CN109096099A (zh) | 3,5-二叔丁基-4-羟基苯甲酸的生产方法 | |
CN102766050A (zh) | 一种富马酸二甲酯的合成方法 | |
CN102643237B (zh) | 1h-咪唑-4-甲酸的制备方法 | |
CN101575293B (zh) | 一种二乙酸碘苯的制备方法 | |
CN103553878B (zh) | 一种烷基环己基苯酚类液晶中间体化合物的制备新方法 | |
CN1966498B (zh) | 六氟环氧丙烷制备工艺 | |
CN101234955B (zh) | 制备3-甲氧基-4-叔丁基甲苯的方法 | |
CN107827742A (zh) | 一种co2直接羧化法制备芳香酸的方法 | |
CN101704788B (zh) | 2-丁基-1,3-二氮杂螺环[4.4]壬烷-1-烯-4-酮的制备方法 | |
CN102452915B (zh) | 3,4-二羟基-2,5-己二酮的制备方法 | |
CN103524313B (zh) | 一种3,5-二甲基苯甲醛的制备方法 | |
CN108129260A (zh) | 一种苯基乙二醇的合成方法 | |
CN103880573A (zh) | 一种合成联苯型化合物的方法 | |
CN111620778A (zh) | 一种5-溴-2-氯苯甲酸的制备方法 | |
CN112142579A (zh) | 一种2-羟基-4-甲氧基二苯甲酮的制备工艺 | |
CN102199076B (zh) | 制备七氟烷的方法 | |
CN208671722U (zh) | 一种苯二甲醚高效冷却器 | |
CN102115431B (zh) | 2,2-二乙氧基乙醇的合成方法 | |
CN101704724A (zh) | 制备高比例反式、反式-4-(4'-烷基环已基)环已基醇类液晶中间体化合物的新方法 | |
CN106146302B (zh) | 丙酸酯的制备方法 | |
CN108774155A (zh) | 一种3-氟-4-氰基苯酚的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG HAIZHOU PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: JIANFENG HAIZHOU PHARMACEUTICAL CO., LTD.;ZHEJIANG PROVINCE |
|
CP03 | Change of name, title or address |
Address after: 317016 Zhejiang Coastal Industrial Park Patentee after: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD. Address before: The coastal industrial park, 2 No. 317016 Zhejiang 317000 Riverside Road Patentee before: ZHEJIANG JIANFENG HAIZHOU PHARMACY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 317016 coastal industrial zone, Linhai City, Zhejiang Province Patentee after: Zhejiang Haizhou Pharmaceutical Co.,Ltd. Address before: 317016 coastal industrial zone, Linhai City, Zhejiang Province Patentee before: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD. |